AXSOME THERAPEUTICS, INC. (AXSM) Net income 2016–2025
AXSOME THERAPEUTICS, INC. (AXSM) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$183.2MFY2025 · since FY2016: -$27.2M → -$183.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$183.2M | +36.2% |
| FY2024 | -$287.2M | -20.1% |
| FY2023 | -$239.2M | -27.8% |
| FY2022 | -$187.1M | -43.5% |
| FY2021 | -$130.4M | -26.7% |
| FY2020 | -$102.9M | -50.6% |
| FY2019 | -$68.3M | -120.7% |
| FY2018 | -$31.0M | -7.0% |
| FY2017 | -$28.9M | -6.4% |
| FY2016 | -$27.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AXSM financial trends
AXSM RevenueAXSM Net marginAXSM Gross profitAXSM Gross marginAXSM Operating incomeAXSM Operating marginAXSM Operating cash flowAXSM Free cash flowAXSM Capital expendituresAXSM Return on equityAXSM Stock buybacksAXSM Dividends paidAXSM Total assetsAXSM Total liabilitiesAXSM Shareholders’ equityAXSM overview →